In vivo characterization of microglia and myelin relation in multiple sclerosis by combined 11C-PBR28 PET and synthetic MRI
- PMID: 36859627
- DOI: 10.1007/s00415-023-11621-5
In vivo characterization of microglia and myelin relation in multiple sclerosis by combined 11C-PBR28 PET and synthetic MRI
Abstract
Background: The in vivo relation between microglia activation and demyelination in multiple sclerosis is still unclear.
Objective: We combined 11C-PBR28 positron emission tomography and rapid estimation of myelin for diagnostic imaging (REMyDI) to characterize the relation between these pathological processes in a heterogeneous MS cohort.
Methods: 11C-PBR28 standardized uptake values normalized by a pseudo-reference region (SUVR) were used to measure activated microglia. A voxelwise analysis compared 11C-PBR28 SUVR in the white matter of 38 MS patients and 16 matched healthy controls. The relative difference in SUVR served as a threshold to classify patients' lesioned, perilesional and normal-appearing white matter as active or inactive. REMyDI was acquired in 27 MS patients for assessing myelin content in active and inactive white matter and its relationship with SUVR. Finally, we investigated the contribution of radiological metrics to clinical outcomes.
Results: 11C-PBR28 SUVR were abnormally higher in several white matter areas in MS. Myelin content was lower in active compared to inactive corresponding white matter regions. An inverse correlation between SUVR and myelin content was found. Radiological metrics correlated with both neurological and cognitive impairment.
Conclusion: our data suggest an inverse relation of microglia activation and myelination, particularly in perilesional white matter tissue.
Keywords: Activated microglia; Demyelination; MRI; PET; Synthetic MRI.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET.Mult Scler. 2020 May;26(6):668-678. doi: 10.1177/1352458519843048. Epub 2019 Apr 11. Mult Scler. 2020. PMID: 30973800 Free PMC article.
-
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1081-92. doi: 10.1007/s00259-015-3043-4. Epub 2015 Apr 2. Eur J Nucl Med Mol Imaging. 2015. PMID: 25833352
-
18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis.Clin Nucl Med. 2018 Sep;43(9):e289-e295. doi: 10.1097/RLU.0000000000002179. Clin Nucl Med. 2018. PMID: 30004939
-
Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions.Front Immunol. 2018 Feb 19;9:255. doi: 10.3389/fimmu.2018.00255. eCollection 2018. Front Immunol. 2018. PMID: 29515576 Free PMC article. Review.
-
Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.Expert Opin Drug Discov. 2015 May;10(5):557-70. doi: 10.1517/17460441.2015.1032240. Epub 2015 Apr 5. Expert Opin Drug Discov. 2015. PMID: 25843125 Review.
Cited by
-
New Imaging Markers in Multiple Sclerosis and Related Disorders: Smoldering Inflammation and the Central Vein Sign.Neuroimaging Clin N Am. 2024 Aug;34(3):359-373. doi: 10.1016/j.nic.2024.03.004. Epub 2024 Apr 23. Neuroimaging Clin N Am. 2024. PMID: 38942521 Free PMC article. Review.
-
The contribution of paramagnetic rim and cortical lesions to physical and cognitive disability at multiple sclerosis clinical onset: evaluating the power of MRI and OCT biomarkers.J Neurol. 2024 Oct;271(10):6702-6714. doi: 10.1007/s00415-024-12622-8. Epub 2024 Aug 19. J Neurol. 2024. PMID: 39155316
References
-
- Dal Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S (2017) Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 133(1):25–42. https://doi.org/10.1007/s00401-016-1636-z - DOI
-
- Dal Bianco A, Grabner G, Kronnerwetter C, Weber M, Kornek B, Kasprian G, Berger T, Leutmezer F, Rommer PS, Trattnig S, Lassmann H, Hametner S (2021) Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI. Brain 144(3):833–847. https://doi.org/10.1093/brain/awaa436 - DOI
-
- Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123(Pt 11):2321–2337. https://doi.org/10.1093/brain/123.11.2321 - DOI - PubMed
-
- Oh U, Fujita M, Ikonomidou VN, Evangelou IE, Matsuura E, Harberts E, Fujimura Y, Richert ND, Ohayon J, Pike VW, Zhang Y, Zoghbi SS, Innis RB, Jacobsonet S (2011) Translocator protein PET imaging for glial activation in multiple sclerosis. J Neuroimmune Pharmacol 6(3):354–361. https://doi.org/10.1007/s11481-010-9243-6 - DOI - PubMed
-
- Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, Airas L (2014) In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195. J Nucl Med 55(6):939–944. https://doi.org/10.2967/jnumed.113.131698 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical